These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2873614

  • 1. A five year follow-up study of tardive dyskinesia.
    Chouinard G, Annable L, Mercier P, Ross-Chouinard A.
    Psychopharmacol Bull; 1986; 22(1):259-63. PubMed ID: 2873614
    [No Abstract] [Full Text] [Related]

  • 2. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
    Casey DE, Povlsen UJ, Meidahl B, Gerlach J.
    Psychopharmacol Bull; 1986; 22(1):250-3. PubMed ID: 2873612
    [No Abstract] [Full Text] [Related]

  • 3. Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.
    Grimes JD.
    Can Med Assoc J; 1982 Mar 01; 126(5):468. PubMed ID: 6121618
    [No Abstract] [Full Text] [Related]

  • 4. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
    Wolf ME, Chevesich J, Lehrer E, Mosnaim AD.
    Biol Psychiatry; 1983 Oct 01; 18(10):1181-8. PubMed ID: 6140032
    [No Abstract] [Full Text] [Related]

  • 5. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA, Caviness JN.
    Mov Disord; 1997 Jan 01; 12(1):119-21. PubMed ID: 8990067
    [No Abstract] [Full Text] [Related]

  • 6. Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics.
    Kulik FA, Wilbur R.
    Psychopharmacol Bull; 1980 Jul 01; 16(3):18-9. PubMed ID: 6105690
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE, Brown WL, Weigel RM, Casey DE.
    J Clin Psychiatry; 1988 Apr 01; 49(4):139-41. PubMed ID: 2895762
    [Abstract] [Full Text] [Related]

  • 8. Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates.
    Lohr JB, Lohr MA, Wasli E, Hilliard B, Larson L, Vardiman E, Wade L, Jeste DV.
    Psychopharmacol Bull; 1987 Apr 01; 23(1):211-4. PubMed ID: 2885888
    [No Abstract] [Full Text] [Related]

  • 9. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P, Bathien N.
    Adv Neurol; 1987 Apr 01; 45():361-6. PubMed ID: 2881446
    [No Abstract] [Full Text] [Related]

  • 10. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC, Atbaşoğlu EC, Balaban H.
    Acta Neurol Belg; 1999 Sep 01; 99(3):176-81. PubMed ID: 10544725
    [Abstract] [Full Text] [Related]

  • 11. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
    Shoulson I.
    Adv Neurol; 1983 Sep 01; 37():259-66. PubMed ID: 6134445
    [No Abstract] [Full Text] [Related]

  • 12. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V, Melamed E.
    J Clin Psychiatry; 1984 Jan 01; 45(1):28-30. PubMed ID: 6141157
    [Abstract] [Full Text] [Related]

  • 13. [Tardive dyskinesias].
    Mignot G.
    Encephale; 1983 Jan 01; 9(2):151-66. PubMed ID: 6139271
    [Abstract] [Full Text] [Related]

  • 14. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM.
    J Clin Psychiatry; 2000 Jan 01; 61 Suppl 4():15-20. PubMed ID: 10739326
    [Abstract] [Full Text] [Related]

  • 15. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE, Kuskowski MA, Caligiuri MP.
    J Clin Psychopharmacol; 2006 Dec 01; 26(6):560-5. PubMed ID: 17110811
    [Abstract] [Full Text] [Related]

  • 16. Followup studies of tardive dyskinesia cases.
    Huang CC.
    Wis Med J; 1984 Dec 01; 83(12):27-9. PubMed ID: 6151758
    [No Abstract] [Full Text] [Related]

  • 17. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Dec 01; 85(2):269-77. PubMed ID: 2858951
    [No Abstract] [Full Text] [Related]

  • 18. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM.
    J Clin Psychiatry; 2004 Dec 01; 65 Suppl 9():16-20. PubMed ID: 15189107
    [Abstract] [Full Text] [Related]

  • 19. Factors related to tardive dyskinesia.
    Chouinard G, Annable L, Ross-Chouinard A, Nestoros JN.
    Am J Psychiatry; 1979 Jan 01; 136(1):79-82. PubMed ID: 31802
    [Abstract] [Full Text] [Related]

  • 20. Neuroleptic-induced tardive dyskinesia.
    Jenner P, Marsden CD.
    Acta Psychiatr Belg; 1987 Jan 01; 87(5):566-98. PubMed ID: 2897761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.